{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:43Z","timestamp":1793413423762,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Susan G. Komen for the Cure (US)","award":["CCR12225655"],"award-info":[{"award-number":["CCR12225655"]}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13058-016-0749-6","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T09:03:37Z","timestamp":1474621417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells"],"prefix":"10.1186","volume":"18","author":[{"given":"Jessica","family":"Byerly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth","family":"Halstead-Nussloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Katsyv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-7318","authenticated-orcid":false,"given":"Hanna Y.","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"issue":"7","key":"749_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011729","volume":"5","author":"HY Irie","year":"2010","unstructured":"Irie HY, Shrestha Y, Selfors LM, Frye F, Iida N, Wang Z, Zou L, Yao J, Lu Y, Epstein CB, et al. PTK6 regulates IGF-1-induced anchorage-independent survival. PLoS One. 2010;5(7), e11729.","journal-title":"PLoS One"},{"key":"749_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/B978-0-12-404717-4.00006-8","volume":"66","author":"EY Zhang","year":"2013","unstructured":"Zhang EY, Kong KF, Altman A. The yin and yang of protein kinase C-theta (PKC theta): a novel drug target for selective immunosuppression. Adv Pharmacol. 2013;66:267\u2013312.","journal-title":"Adv Pharmacol."},{"issue":"7","key":"749_CR3","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/S0021-9258(18)53494-3","volume":"268","author":"G Baier","year":"1993","unstructured":"Baier G, Telford D, Giampa L, Coggeshall KM, Baier-Bitterlich G, Isakov N, Altman A. Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem. 1993;268(7):4997\u20135004.","journal-title":"J Biol Chem"},{"issue":"3","key":"749_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/stem.160178","volume":"16","author":"N Meller","year":"1998","unstructured":"Meller N, Altman A, Isakov N. New perspectives on PKC theta, a member of the novel subfamily of protein kinase C. Stem Cells. 1998;16(3):178\u201392.","journal-title":"Stem Cells"},{"issue":"2","key":"749_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/cimm.1999.1478","volume":"193","author":"N Meller","year":"1999","unstructured":"Meller N, Elitzur Y, Isakov N. Protein kinase C-theta (PKC theta) distribution analysis in hematopoietic cells: proliferating T cells exhibit high proportions of PKC theta in the particulate fraction. Cell Immunol. 1999;193(2):185\u201393.","journal-title":"Cell Immunol"},{"issue":"8","key":"749_CR6","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.4049\/jimmunol.167.8.4358","volume":"167","author":"YM Vyas","year":"2001","unstructured":"Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, Jung S, Burkhardt JK, Dupont B. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol. 2001;167(8):4358\u201367.","journal-title":"J Immunol"},{"issue":"7","key":"749_CR7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/eji.200324625","volume":"34","author":"A Altman","year":"2004","unstructured":"Altman A, Kaminski S, Busuttil V, Droin N, Hu J, Tadevosyan Y, Hipskind RA, Villalba M. Positive feedback regulation of PLCgamma1\/Ca(2+) signaling by PKC theta in restimulated T cells via a Tec kinase-dependent pathway. Eur J Immunol. 2004;34(7):2001\u201311.","journal-title":"Eur J Immunol"},{"issue":"3","key":"749_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jmb.2005.10.043","volume":"355","author":"S Manicassamy","year":"2006","unstructured":"Manicassamy S, Sadim M, Ye RD, Sun Z. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells. J Mol Biol. 2006;355(3):347\u201359.","journal-title":"J Mol Biol"},{"issue":"5","key":"749_CR9","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.4049\/jimmunol.178.5.2932","volume":"178","author":"SD Saibil","year":"2007","unstructured":"Saibil SD, Jones RG, Deenick EK, Liadis N, Elford AR, Vainberg MG, Baerg H, Woodgett JR, Gerondakis S, Ohashi PS. CD4+ and CD8+ T cell survival is regulated differentially by protein kinase C theta, c-Rel, and protein kinase B. J Immunol. 2007;178(5):2932\u20139.","journal-title":"J Immunol"},{"issue":"40","key":"749_CR10","doi-asserted-by":"publisher","first-page":"14374","DOI":"10.1073\/pnas.0506250102","volume":"102","author":"BJ Marsland","year":"2005","unstructured":"Marsland BJ, Nembrini C, Schmitz N, Abel B, Krautwald S, Bachmann MF, Kopf M. Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T cell effector and memory responses. Proc Natl Acad Sci USA. 2005;102(40):14374\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"749_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20032229","volume":"200","author":"BJ Marsland","year":"2004","unstructured":"Marsland BJ, Soos TJ, Spath G, Littman DR, Kopf M. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J Exp Med. 2004;200(2):181\u20139.","journal-title":"J Exp Med"},{"issue":"12","key":"749_CR12","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1172\/JCI39692","volume":"119","author":"JO Valenzuela","year":"2009","unstructured":"Valenzuela JO, Iclozan C, Hossain MS, Prlic M, Hopewell E, Bronk CC, Wang J, Celis E, Engelman RW, Blazar BR, et al. PKC theta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J Clin Invest. 2009;119(12):3774\u201386.","journal-title":"J Clin Invest"},{"issue":"6","key":"749_CR13","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.4049\/jimmunol.178.6.3466","volume":"178","author":"BJ Marsland","year":"2007","unstructured":"Marsland BJ, Nembrini C, Grun K, Reissmann R, Kurrer M, Leipner C, Kopf M. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J Immunol. 2007;178(6):3466\u201373.","journal-title":"J Immunol"},{"issue":"6","key":"749_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/08916930600907954","volume":"39","author":"K Anderson","year":"2006","unstructured":"Anderson K, Fitzgerald M, Dupont M, Wang T, Paz N, Dorsch M, Healy A, Xu Y, Ocain T, Schopf L, et al. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases. Autoimmunity. 2006;39(6):469\u201378.","journal-title":"Autoimmunity"},{"issue":"5","key":"749_CR15","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.4049\/jimmunol.176.5.2872","volume":"176","author":"SL Tan","year":"2006","unstructured":"Tan SL, Zhao J, Bi C, Chen XC, Hepburn DL, Wang J, Sedgwick JD, Chintalacharuvu SR, Na S. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J Immunol. 2006;176(5):2872\u20139.","journal-title":"J Immunol"},{"issue":"10","key":"749_CR16","doi-asserted-by":"publisher","first-page":"6440","DOI":"10.4049\/jimmunol.173.10.6440","volume":"173","author":"S Salek-Ardakani","year":"2004","unstructured":"Salek-Ardakani S, So T, Halteman BS, Altman A, Croft M. Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J Immunol. 2004;173(10):6440\u20137.","journal-title":"J Immunol"},{"issue":"12 Pt 1","key":"749_CR17","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1158\/1078-0432.CCR-04-0630","volume":"10","author":"P Blay","year":"2004","unstructured":"Blay P, Astudillo A, Buesa JM, Campo E, Abad M, Garcia-Garcia J, Miquel R, Marco V, Sierra M, Losa R, et al. Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin Cancer Res. 2004;10(12 Pt 1):4089\u201395.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"749_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/path.1546","volume":"202","author":"M Debiec-Rychter","year":"2004","unstructured":"Debiec-Rychter M, Wasag B, Stul M, De Wever I, Van Oosterom A, Hagemeijer A, Sciot R. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. J Pathol. 2004;202(4):430\u20138.","journal-title":"J Pathol"},{"issue":"42","key":"749_CR19","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1038\/onc.2008.177","volume":"27","author":"WB Ou","year":"2008","unstructured":"Ou WB, Zhu MJ, Demetri GD, Fletcher CD, Fletcher JA. Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors. Oncogene. 2008;27(42):5624\u201334.","journal-title":"Oncogene"},{"issue":"12","key":"749_CR20","first-page":"4009","volume":"117","author":"K Belguise","year":"2007","unstructured":"Belguise K, Sonenshein GE. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. J Clin Invest. 2007;117(12):4009\u201321.","journal-title":"J Clin Invest"},{"issue":"47","key":"749_CR21","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1038\/onc.2011.659","volume":"31","author":"K Belguise","year":"2012","unstructured":"Belguise K, Milord S, Galtier F, Moquet-Torcy G, Piechaczyk M, Chalbos D. The PKC theta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene. 2012;31(47):4889\u201397.","journal-title":"Oncogene"},{"key":"749_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gdata.2014.11.002","volume":"3","author":"A Zafar","year":"2015","unstructured":"Zafar A, Hardy K, Wu F, Li J, Rao S. The role of protein kinase-C theta in control of epithelial to mesenchymal transition and cancer stem cell formation. Genom Data. 2015;3:28\u201332.","journal-title":"Genom Data."},{"issue":"16","key":"749_CR23","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1128\/MCB.01693-13","volume":"34","author":"A Zafar","year":"2014","unstructured":"Zafar A, Wu F, Hardy K, Li J, Tu WJ, McCuaig R, Harris J, Khanna KK, Attema J, Gregory PA, et al. Chromatinized protein kinase C-theta directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells. Mol Cell Biol. 2014;34(16):2961\u201380.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"749_CR24","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1128\/MCB.16.4.1842","volume":"16","author":"G Baier-Bitterlich","year":"1996","unstructured":"Baier-Bitterlich G, Uberall F, Bauer B, Fresser F, Wachter H, Grunicke H, Utermann G, Altman A, Baier G. Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol. 1996;16(4):1842\u201350.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"749_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.200505087","volume":"171","author":"HY Irie","year":"2005","unstructured":"Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol. 2005;171(6):1023\u201334.","journal-title":"J Cell Biol"},{"key":"749_CR26","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","DOI":"10.1038\/nature11412"},{"issue":"7403","key":"749_CR27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature"},{"issue":"3","key":"749_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/A:1006217413089","volume":"55","author":"JL Chou","year":"1999","unstructured":"Chou JL, Fan Z, DeBlasio T, Koff A, Rosen N, Mendelsohn J. Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor. Breast Cancer Res Treat. 1999;55(3):267\u201383.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"749_CR29","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1172\/JCI35636","volume":"118","author":"H Skvara","year":"2008","unstructured":"Skvara H, Dawid M, Kleyn E, Wolff B, Meingassner JG, Knight H, Dumortier T, Kopp T, Fallahi N, Stary G, et al. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest. 2008;118(9):3151\u20139.","journal-title":"J Clin Invest"},{"issue":"3","key":"749_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cell.2015.01.001","volume":"160","author":"CE Antal","year":"2015","unstructured":"Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, et al. Cancer-associated protein kinase C mutations reveal kinase\u2019s role as tumor suppressor. Cell. 2015;160(3):489\u2013502.","journal-title":"Cell"},{"issue":"2","key":"749_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/1568009023333908","volume":"2","author":"M Villalba","year":"2002","unstructured":"Villalba M, Altman A. Protein kinase C-theta (PKC theta), a potential drug target for therapeutic intervention with human T cell leukemias. Curr Cancer Drug Targets. 2002;2(2):125\u201337.","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"749_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1309\/AJCP9KHD7DCHWLMO","volume":"136","author":"RS Gonzalez","year":"2011","unstructured":"Gonzalez RS, Carlson G, Page AJ, Cohen C. Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome. Am J Clin Pathol. 2011;136(1):74\u201380.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"749_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1021\/jm500669m","volume":"58","author":"DM George","year":"2015","unstructured":"George DM, Breinlinger EC, Friedman M, Zhang Y, Wang J, Argiriadi M, Bansal-Pakala P, Barth M, Duignan DB, Honore P, et al. Discovery of selective and orally bioavailable protein kinase C theta (PKC theta) inhibitors from a fragment hit. J Med Chem. 2015;58(1):222\u201336.","journal-title":"J Med Chem"},{"key":"749_CR34","doi-asserted-by":"publisher","first-page":"314620","DOI":"10.1155\/2015\/314620","volume":"2015","author":"L Guery","year":"2015","unstructured":"Guery L, Hugues S. Th17 Cell plasticity and functions in cancer immunity. Biomed Res Int. 2015;2015:314620.","journal-title":"Biomed Res Int."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-016-0749-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T02:15:11Z","timestamp":1657332911000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-016-0749-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1186\/s13058-016-0749-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]},"article-number":"95"}}